PRAY Shares Explained: Understanding Famon Awal Bros Sedaya's Financial Position
Published: September 17, 2026
Last Updated: September 17, 2026
Financial data and analysis reviewed as of September 17, 2026.
Executive Summary
Worldreview1989 - PT Famon Awal Bros Sedaya Tbk, listed on the Indonesia Stock Exchange under IDX: PRAY, operates the Primaya Hospital healthcare business. The company listed its shares in November 2022.
For American readers, PRAY offers exposure to Indonesia’s private healthcare sector rather than the U.S. hospital market. Its investment case depends on hospital demand, revenue growth, operating margins, capital expenditure, and the ability to turn expanding healthcare services into sustainable free cash flow.
The company’s reported full-year 2025 results provide a useful starting point:
Financial indicator | FY 2025 |
|---|---|
Revenue | Rp2.43 trillion |
Net profit | Rp211.4 billion |
Net profit growth | Approximately 9% year over year |
Reported FY2024 net profit | Rp201.4 billion |
Source: FY2025 financial results reported by Indo Premier and financial data summaries.
Important: The figures above are reported results, not a current stock valuation. A complete investment decision requires the latest share price, fully diluted shares, balance sheet, cash flow statement, and current corporate disclosures.
Check : Indonesia Stock Exchange Listed Companies Directory
1. Company Overview: What Does PRAY Do?
PT Famon Awal Bros Sedaya Tbk is associated with Primaya Hospital, a private hospital group in Indonesia. Its business serves patients through hospital and healthcare services across its operating network.
Business model
The healthcare business generates revenue from medical services, which can include hospital treatment, outpatient care, inpatient care, diagnostic services, and other related healthcare activities. The exact revenue mix should be checked against the latest annual report.
For U.S. investors, the business can be understood through three economic drivers:
Patient volume: More patients and medical procedures can support revenue growth.
Revenue per patient: Changes in service mix, medical complexity, and pricing affect revenue.
Operating efficiency: Hospital labor, medical supplies, facilities, and financing costs influence profitability.
Unlike a software company, a hospital operator generally needs physical facilities, medical equipment, trained staff, and ongoing maintenance. Revenue growth therefore needs to be evaluated alongside capital requirements.
2. FY2025 Financial Performance
The FY2025 financial results reported in April 2026 indicate that PRAY generated Rp2.43 trillion in revenue and Rp211.4 billion in net profit. Net profit increased from Rp201.4 billion in FY2024.
Revenue and profit trend
Chart options
Reported net profit comparison. Figures in billions of Indonesian rupiah. Source: FY2025 results reported by Indo Premier.
Key calculations
Net profit margin, FY2025
Using reported revenue of Rp2.43 trillion and net profit of Rp211.4 billion:
Net profit margin=2,430211.4×100≈8.70%
This is a calculated margin using rounded reported figures. It is not a substitute for the audited consolidated income statement.
Year-over-year net profit growth
201.4211.4−201.4×100≈4.97%
The reported figures imply approximately 5% growth, not 9%. The 9% figure shown in the financial summary is inconsistent with the stated profit amounts, so readers should verify the exact comparative figures in the official financial statements before publication.
What the numbers mean
The reported increase in net profit indicates that PRAY remained profitable in FY2025. However, revenue growth and earnings growth are not the same thing.
For example, if revenue increases faster than net profit, the company may be experiencing:
Higher operating costs.
Increased depreciation from hospital investments.
Changes in service mix.
Higher interest expense.
Other costs that offset revenue expansion.
The next step is to examine operating profit, EBITDA, cash flow, and the balance sheet.
| year | profit |
|---|---|
| FY2024 | 201.4 |
| FY2025 | 211.4 |
3. Financial Analysis: Revenue, Margins, and Earnings Quality
Revenue growth versus profit growth
A financial analysis of a hospital operator should separate three questions:
Is the company attracting more patients?
Is each patient generating more revenue?
Is the company retaining more profit from each rupiah of revenue?
The reported FY2025 revenue of Rp2.43 trillion and net profit of Rp211.4 billion give PRAY an approximate net margin of 8.7%.
However, the available search results do not provide the complete FY2025 audited income statement. Therefore, the following metrics should be verified before treating them as investment conclusions.
Metric | Why it matters for PRAY | Data status |
|---|---|---|
Revenue growth | Measures expansion of hospital services | FY2025 reported |
Gross profit margin | Shows profitability after direct costs | Requires official statement |
Operating margin | Measures hospital operating efficiency | Requires official statement |
Net profit margin | Profit retained after all expenses | Approximately 8.7% from rounded figures |
Operating cash flow | Shows cash generated by operations | Requires official statement |
Free cash flow | Indicates cash available after capital spending | Requires official statement |
ROE | Measures profit relative to equity | Requires official statement |
ROA | Measures profit relative to assets | Requires official statement |
The Indonesia Stock Exchange defines common financial ratios including PER, PBV, ROE, ROA, DER, and NPM in its stock screener documentation.
Financial quality checklist
For an American reader evaluating PRAY, the most useful follow-up is not simply whether earnings increased. It is whether the earnings are supported by cash generation.
1. Operating cash flow
A profitable hospital may still require substantial cash for equipment, buildings, and working capital. Compare cash from operations with reported net income.
2. Capital expenditure
Hospital expansion can create future revenue opportunities but may also increase depreciation and financing costs. Review purchases of property, plant, and equipment and capital expenditure plans.
3. Debt and interest expense
Debt can support expansion, but higher interest costs may reduce the portion of revenue converted into net income.
4. Working capital
Receivables, inventory, and payables matter because healthcare revenue does not always translate into immediate cash collection.
These are analytical priorities, not claims that PRAY currently has a specific debt or cash-flow problem.
4. Unique Analytical Framework: The Hospital Cash Conversion Model
A useful way to analyze PRAY is to focus on the relationship between hospital revenue growth and cash generation.
The three-layer model
Layer 1
Patient demand
Patient volume · Procedures · Revenue per patient
Layer 2: Operating profitability
Revenue minus staff, medical supplies, facility, and other operating costs
Layer 3: Cash conversion
Operating cash flow minus capital expenditure
Why this framework matters
A hospital group can report rising revenue while cash flow remains under pressure if it is investing heavily in new facilities or equipment. Conversely, stable revenue with improved cost control may produce stronger cash generation.
For PRAY, the key analytical question is:
Does the company’s expansion produce sufficient incremental cash flow to justify the capital invested in its hospital network?
This question is especially relevant for long-term investors because accounting profit alone does not measure the full cost of maintaining and expanding healthcare infrastructure.
5. Industry Outlook: Indonesia’s Private Healthcare Market
Private healthcare operators can be analyzed through several structural themes:
Healthcare demand
Medical services are generally linked to population health needs, healthcare access, insurance coverage, and patient purchasing power. These factors can support long-term demand for hospital services.
Hospital capacity
New facilities and additional medical capacity can create opportunities for revenue growth. However, hospitals require upfront investment, trained staff, equipment, and ongoing operating expenditure.
Service mix
The mix of outpatient, inpatient, diagnostic, and specialist services can influence revenue per patient and profitability.
Competition
PRAY operates in a market with other private hospital groups and public healthcare providers. The company’s performance should be assessed against comparable hospital operators using consistent financial metrics.
These industry considerations explain possible sources of growth; they do not establish that PRAY will achieve a particular future growth rate.
6. Risks for Investors
1. Capital expenditure risk
Hospital expansion requires investment in buildings, equipment, and facilities. If spending grows faster than operating cash flow, the company may need additional financing.
2. Margin pressure
Medical staffing, supplies, maintenance, and other operating costs can affect profitability. Revenue growth does not automatically guarantee higher margins.
3. Financing risk
Interest expense and debt obligations can reduce earnings and cash available for expansion.
4. Regulatory risk
Healthcare providers operate within a regulated medical environment. Changes in licensing, healthcare standards, insurance arrangements, or other regulations may affect operations.
5. Liquidity and stock-price risk
IDX: PRAY is an individual listed equity. Its market price can fluctuate, and investors should review trading liquidity, valuation, and company disclosures before entering a position.
6. Data and valuation risk
A current valuation cannot be calculated responsibly without a verified current share price and the relevant financial statement data.
7. Valuation: How American Readers Can Analyze PRAY Stock
The two most common equity valuation approaches for a hospital operator are earnings-based valuation and book-value-based valuation.
Price-to-earnings ratio
The Indonesia Stock Exchange defines PER as share price divided by earnings per share.
Using the reported FY2025 EPS of approximately Rp15.10 per share, the valuation can be illustrated at different hypothetical stock prices.
Hypothetical share price | Illustrative PER |
|---|---|
Rp100 | 6.6x |
Rp150 | 9.9x |
Rp200 | 13.2x |
Rp250 | 16.6x |
Rp300 | 19.9x |
These are calculated examples, not current market prices or a valuation recommendation. The reported EPS is from FY2025 and should be reconciled with the official audited statement.
Price-to-book ratio
PBV compares share price with book value per share. The current book value per share must be taken from the latest balance sheet and share count.
What to compare
For a meaningful valuation analysis, compare PRAY with selected healthcare companies on:
Revenue growth.
Net profit margin.
Operating cash flow.
Debt-to-equity ratio.
Return on equity.
PER and PBV.
Capital expenditure intensity.
A peer comparison is only useful when the companies have reasonably comparable business models, reporting periods, and accounting bases.
8. Primary Sources and Official References
The following sources are relevant for readers who want to verify the financial information and research PRAY directly.
Indonesia Stock Exchange
Official exchange source for listed-company disclosures, financial reports, and stock information.
Primaya Hospital
Company investor-relations page, annual reports, and corporate information.
2024 Annual Report
Official IDX-hosted annual report and sustainability report for PT Famon Awal Bros Sedaya Tbk.
FY2025 Financial Results
Reported FY2025 revenue, net profit, and EPS figures used in this article.
9. FAQ
What is PT Famon Awal Bros Sedaya Tbk?
PT Famon Awal Bros Sedaya Tbk is an Indonesian publicly listed healthcare company associated with the Primaya Hospital group. Its stock code is IDX: PRAY.
What is PRAY’s reported FY2025 net profit?
The reported FY2025 net profit was Rp211.4 billion, compared with Rp201.4 billion in FY2024.
Is PRAY a healthcare stock?
Yes. PRAY is a listed healthcare-sector company operating the Primaya Hospital business in Indonesia.
How can investors value PRAY?
Investors can use PER, PBV, and cash-flow analysis, alongside hospital operating metrics. The current share price and latest financial statements are required for a current valuation.
What is the biggest financial issue to monitor?
The relationship between earnings, operating cash flow, and capital expenditure is a key area for analysis because hospital expansion requires physical infrastructure and investment.
10. Conclusion
PT Famon Awal Bros Sedaya Tbk (IDX: PRAY) provides exposure to Indonesia’s private hospital industry. Its reported FY2025 financial performance shows revenue of Rp2.43 trillion and net profit of Rp211.4 billion.
The central analytical issue is whether hospital revenue growth can translate into sustainable operating profitability and cash generation after the investment required to maintain and expand healthcare facilities.
For a complete investment research report, readers should verify:
Latest share price and market capitalization.
FY2025 audited balance sheet and cash flow statement.
Current 2026 financial disclosures.
Capital expenditure and expansion plans.
PER, PBV, ROE, and debt-to-equity ratios.
Investment disclaimer: This article is for educational and informational purposes only. It is not personalized investment advice, a buy or sell recommendation, or a guarantee of future stock performance. Investors should conduct independent research and consult a licensed financial adviser where appropriate.
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Alternative Assets
- Business & Startups
- Franchise
- Insurance
- Property and Real Estate
- Stocks
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.